Idarucizumab (praxbind) for dabigatran reversal in patients undergoing heart transplantation: retrospective cohort of 8 patients and a short review.
Topic:
Nonpharmacological Treatment
Congress Presentation
1 more presentation in this session
Access the full session
About the event
